RT Journal Article
SR Electronic
T1 Type construction in qualitative health research and its relevance in complementary and integrative medicine. Two studies about patients’ experiences with herbal medicine preparations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.13.22276352
DO 10.1101/2022.06.13.22276352
A1 Canella, Claudia
A1 Wolfensberger, Balz
A1 Witt, Claudia M.
YR 2022
UL http://medrxiv.org/content/early/2022/06/17/2022.06.13.22276352.abstract
AB In this article, we explore the method of type construction in qualitative health research in the field of complementary and integrative medicine. We applied type construction to research questions in phytotherapy about the everyday life experiences of patients using two specific herbal medicine preparations. In total, 21 patients participated in two consecutive qualitative studies. The collected data incorporated patient diaries, face-to-face interviews and pre- and posttreatment questionnaires. A type construction approach was applied for data analysis. In the Passiflora-study, three distinct biographical narrative types attributed to different experiences when using a specific ethanolic extract of Passiflora incarnata were identified. In the Angelica-study, four types of thematic dimensions of experiences with a specific ethanolic extract of Angelica archangelica were identified. Type construction in qualitative health research can contribute to evidence-based phytotherapy and complementary and integrative medicine in general by supporting shared decision making and individualized treatment approaches.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe two studies were funded by Ceres Heilmittel AG, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, but were regularly informed about the proceeding of the research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval and consent to participate: All procedures performed in the two studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments and with the ethical standards of the ethics committee of Zurich, Switzerland. Both studies did not fall under the regulation of the Human Research Act of Switzerland which was confirmed by the Ethics Committee of Zurich, Switzerland (Passiflora-Study: KEK-ZH-Nr. 59-2015, July 2015 / Angelica-Study: BASEC-Nr. Req-2017-00456, June 2017). Consent to participate and for publication: Written informed consent was obtained from all individual participants included in the study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsCIMcomplementary and integrative medicine